ReviewFrontiers in oncology2022

Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade.

Dipta Dey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.